Retatrutide's proposed mechanism of action involves GLP-1 receptor activation to slow gastric emptying and promote satiety, GIP receptor activation to support insulin secretion and adipose tissue regulation, and glucagon receptor agonism, which in trial settings has been associated with increased energy expenditure and lipolysis
This does not affect reconstitution, but it means the mechanism of action differs
Compounding allows a pharmacist to prepare the precise dose prescribed by your veterinarian for your individual cat
Laboratory & Research Disclaimer: Products provided by Remedium Research are intended strictly for in vitro analytical, laboratory, and scientific evaluation
That means no compounding, no guesswork, just FDA-approved, brand-name medications delivered with expert care